GB/T 21751-2008
AbolishedChemicals - Test method of mammalian spermatogonial chromosome aberration
化学品 哺乳动物精原细胞染色体畸变试验方法
Application Summary AI generated
This standard specifies the in vivo test method for detecting chromosome aberrations in mammalian spermatogonial cells, used to evaluate the genotoxic potential of chemicals. It is applied in the safety assessment of industrial chemicals, pesticides, and pharmaceuticals, particularly within regulatory toxicology testing frameworks. The method is relevant for identifying substances that may cause heritable genetic damage in male germ cells.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.